Dr. Michael D Hogarty M.D.
Hematologist (Pediatric) | Pediatric Hematology-Oncology
34th & Civic Center Blvd Children's Hospital Philadelphia PA, 19104About
I'm a pediatric oncologist with both clinical and research responsibilities. On the clinical side, I have developed expertise in the management of patients with neuroblastoma, germ cell tumors, and hi ...
Education and Training
Columbia Univ Coll of Physicians And Surgeons, New York Ny 1990
Columbia University College of Physicians and Surgeons 1990
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM- Medical Oncology
Provider Details
Expert Publications
Data provided by the National Library of Medicine- The requirement for evasion of programmed cell death in neuroblastomas with MYCN amplification.
- Expression of a MYCN-interacting isoform of the tumor suppressor BIN1 is reduced in neuroblastomas with unfavorable biological features.
- Targeting programmed cell death pathways with experimental therapeutics:
- BH3 peptidomimetics potently activate apoptosis and demonstrate single agent efficacy in neuroblastoma.
- Mutations in PIK3CA are infrequent in neuroblastoma.
- Cutaneous metastatic chordoma with concomitant tuberous sclerosis.
- Neuroblastoma.
- Deregulated Wnt/beta-catenin program in high-risk neuroblastomas without MYCN amplification.
- N-myc augments death and attenuates protective effects of Bcl-2 in trophically stressed neuroblastoma cells.
- ODC1 is a critical determinant of MYCN oncogenesis and a therapeutic target in neuroblastoma.
- Influence of neuroblastoma stage on serum-based detection of MYCN amplification.
- Clusterin, a haploinsufficient tumor suppressor gene in neuroblastomas.
- Small-molecule BH3 mimetics to antagonize Bcl-2-homolog survival functions in cancer.
- Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study.
- Mcl1 downregulation sensitizes neuroblastoma to cytotoxic chemotherapy and small molecule Bcl2-family antagonists.
Awards
- 2009 St. Baldrick's Foundation Research Award
- The Children's Hospital of Philadelphia 2005 Foerderer-Murray Award
- University Research Foundation Award, 2005 University of Pennsylvania
- 2000 Burroughs Wellcome Fund Career Award in the Biomedical Sciences
- American Society of Clinical Oncology 1999 Career Development Award
Treatments
- Leukemia
- Dermal Aesthetics
- Extra Corporeal Shockwave Therapy
Professional Memberships
- Member Participation in scientific committees
Fellowships
- Pediatric Hematology/Oncology - The Children's Hospital of Philadelphia, Philadelphia, PA
Experience & Accolades
- Member 2009Member, Search Committee for Pediatric Oncology Survivorship Faculty
- Member2008 - 2014 Co-chair, Pediatric Protocol Review Committee, Division of Oncology and Abramson Family Cancer Cent
- Resident2008 - 2014 Physician- Scientist Mentor Committee
Dr. Michael D Hogarty M.D.'s Practice location
Dr. Michael D Hogarty M.D.'s reviews
Write ReviewPatient Experience with Dr. Hogarty
Recommended Articles
- Nurse Midwife: A Job Description
A nurse midwife is a healthcare professional whose job is to offer support as well as guidance all through the birthing process. As we all are aware, nurse midwives have been around for quite a long time now. However, during recent times they have been regaining popularity again. As more and more...
- How Long Can Jock Itch Last?
Jock Itch is an infection that usually targets the groin. It spreads over the skin of the thighs, near the genitals and the buttocks in men and women. It is mostly caused by a Dermatophyte fungus and the Candida Albicans yeast. The result is extreme redness of the skin, severe rashes, and itching,...
- Purpura
PurpuraPurpura refers to purple-colored spots that are usually seen on the skin, including mucous membranes and other organs. It is also called skin hemorrhages or blood spots.Purpura is usually recognized when there is pooling of blood under the skin due to ruptured small blood vessels. The size of...
- How Is Leukemia Diagnosed?
Leukemia in its early stages may present no signs or symptoms, as these only appear when the leukemia cells have taken over a large number of normal blood cells. A person with leukemia is very lucky indeed if early-stage detection occurs incidentally, through a routine blood test or one done for...
- Potential Causes of Leukopenia
IntroductionA decrease in the number of white blood cells (WBCs) is referred to as leukopenia. There are several causes for leukopenia. It may be due to certain drugs, cancer, radiation and chemotherapy for cancer, stem cell transplant, surgery, steroids, or autoimmune disorders. The immune system...
- Study Finds 3% of Pediatric Non-Hodgkin Lymphoma Cases Are Transplant Recipients
Lymphoma is a blood cancer that affects both children and adults.Lymphoma begins its growth in the lymphatic white blood cells of the lymph system. This system is a major warrior in fighting off infections and diseases. It is part of the body’s immunity team.The lymph system loops throughout the...
Nearby Providers
- Dr. Mortimer Poncz M.D.34th & Civic Center Blvd Philadelphia PA 19104
- Dr. Stephan A Grupp M.D.34th & Civic Center Blvd Philadelphia PA 19104
- Dr. Susan R Rheingold M.D.34th & Civic Center Blvd Philadelphia PA 19104
- Dr. Nancy J Bunin M.D.34th & Civic Center Blvd Philadelphia PA 19104
- Dr. Peter C Adamson M.D.34th & Civic Center Blvd. Philadelphia PA 19104
- Dr. Naomi Balamuth M.D.34th & Civic Center Blvd Philadelphia PA 19104